WallStreetZenWallStreetZen

NASDAQ: EWTX
Edgewise Therapeutics Inc Stock Ownership - Who owns Edgewise Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Edgewise Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Alan J. RussellChief Scientific Officer2026-07-01130,352$39.41
$5.14MSell
Alan J. RussellChief Scientific Officer2026-07-0169,648$0.18
$12.54kBuy
Alan J. RussellChief Scientific Officer2026-07-01130,352$0.45
$58.66kBuy
Alan J. RussellChief Scientific Officer2026-07-0169,648$39.41
$2.74MSell
Joanne M. DonovanCMO2026-05-0550,000$7.08
$354.00kBuy
Joanne M. DonovanCMO2026-05-0550,000$38.57
$1.93MSell
Joanne M. DonovanCMO2026-05-045,230$31.29
$163.66kSell
Joanne M. DonovanCMO2026-04-0128,662$32.31
$926.10kSell
Joanne M. DonovanCMO2026-04-0128,662$7.08
$202.93kBuy
Joanne M. DonovanCMO2026-03-3121,338$32.12
$685.31kSell

1 of 4

EWTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EWTX insiders and whales buy or sell their stock.

EWTX Shareholders

What type of owners hold Edgewise Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC14.42%15,518,492$638.12MInstitution
Ra Capital Management LP9.69%10,428,437$428.82MInstitution
Paradigm Biocapital Advisors LP6.85%7,365,038$302.85MInstitution
Baker Bros Advisors LP6.11%6,575,940$270.40MInstitution
Blackrock Inc6.02%6,472,991$266.17MInstitution
Holdings A. Novo5.64%6,071,703$249.67MInsider
Janus Henderson Group PLC5.50%5,915,556$243.25MInstitution
Novo Holdings A4.97%5,350,000$219.99MInstitution
Driehaus Capital Management LLC4.16%4,477,942$184.13MInstitution
Siren LLC4.12%4,430,263$182.17MInstitution

1 of 3

EWTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EWTX88.33%11.67%Net SellingNet Selling
CELC84.54%15.46%Net SellingNet Selling
TNGX68.39%31.61%Net SellingNet Buying
MANE62.15%15.06%Net Buying
CAI41.84%58.16%Net SellingNet Buying
View Top Biotech Stocks

Edgewise Therapeutics Stock Ownership FAQ

Who owns Edgewise Therapeutics?

Edgewise Therapeutics (NASDAQ: EWTX) is owned by 110.17% institutional shareholders, 14.55% Edgewise Therapeutics insiders, and 0.00% retail investors. Holdings A. Novo is the largest individual Edgewise Therapeutics shareholder, owning 6.07M shares representing 5.64% of the company. Holdings A. Novo's Edgewise Therapeutics shares are currently valued at $233.34M.

If you're new to stock investing, here's how to buy Edgewise Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.